Merit Medical (MMSI) stock slides 8% as founder exits chair role and early Q4 revenue lands
Merit Medical shares fell 8.1% to $85.66 Friday after the company posted preliminary Q4 revenue of $389 million–$395 million and named F. Ann Millner board chair, replacing founder Fred Lampropoulos. The stock touched $84.75. Full results and 2026 guidance are due Feb. 24. Lampropoulos will serve as a consultant through March.